548 Episodo

  1. A Heart Attack that Led to a Rare Disease Diagnosis

    Publicado: 30/1/2025
  2. Targeting Rare Liver Diseases with Gene Editing Therapies

    Publicado: 23/1/2025
  3. Using AI to De-Risk Rare Disease Drug Development

    Publicado: 16/1/2025
  4. Addressing a Growing Demand for Plasma-Derived Therapies

    Publicado: 9/1/2025
  5. Empowering Patients with Data to Drive Drug Development

    Publicado: 2/1/2025
  6. How Advocates Are Advancing a Treatment for an Ultra-Rare Disease

    Publicado: 26/12/2024
  7. Engineering B Cells to Produce Therapeutic Proteins

    Publicado: 19/12/2024
  8. A Pipeline Win as BridgeBio Learns to Balance Theory with Practice

    Publicado: 12/12/2024
  9. Considering What It Will Take for Payers to Embrace Advances in Sequencing

    Publicado: 5/12/2024
  10. Finding Strength

    Publicado: 27/11/2024
  11. A Non-Profit Works to Advance a DMD Gene Therapy

    Publicado: 21/11/2024
  12. Accepting What We Can’t Understand

    Publicado: 14/11/2024
  13. A Gene Therapy Company Born from a Father’s Efforts to Save his Daughter

    Publicado: 7/11/2024
  14. Lowering Barriers to Clinical Trial Participation with Do-It-Yourself Blood Sample Collection

    Publicado: 31/10/2024
  15. Scaling N-of-1 Therapies to Viability

    Publicado: 24/10/2024
  16. Building Gene Therapies that Address Gain and Loss of Function Simultaneously

    Publicado: 17/10/2024
  17. How One Woman Climbed from Patient to Advocate

    Publicado: 10/10/2024
  18. Shortening the Diagnostic Odyssey

    Publicado: 3/10/2024
  19. Making Exomes More Revealing

    Publicado: 26/9/2024
  20. How One Patient Organization Catalyzed Drug Development

    Publicado: 19/9/2024

2 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site